EE+ POEM Archive
For patients with provoked venous thromboembolism and at least one ongoing risk factor, 12 months of apixaban is better than 3 months
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "For Patients With Provoked Venous Thromboembolism and at Least One Ongoing Risk Factor, 12 Months of Apixaban Is Better Than 3 Months." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377496/all/For_patients_with_provoked_venous_thromboembolism_and_at_least_one_ongoing_risk_factor__12_months_of_apixaban_is_better_than_3_months.
For patients with provoked venous thromboembolism and at least one ongoing risk factor, 12 months of apixaban is better than 3 months. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377496/all/For_patients_with_provoked_venous_thromboembolism_and_at_least_one_ongoing_risk_factor__12_months_of_apixaban_is_better_than_3_months. Accessed December 5, 2025.
For patients with provoked venous thromboembolism and at least one ongoing risk factor, 12 months of apixaban is better than 3 months. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377496/all/For_patients_with_provoked_venous_thromboembolism_and_at_least_one_ongoing_risk_factor__12_months_of_apixaban_is_better_than_3_months
For Patients With Provoked Venous Thromboembolism and at Least One Ongoing Risk Factor, 12 Months of Apixaban Is Better Than 3 Months [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377496/all/For_patients_with_provoked_venous_thromboembolism_and_at_least_one_ongoing_risk_factor__12_months_of_apixaban_is_better_than_3_months.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - For patients with provoked venous thromboembolism and at least one ongoing risk factor, 12 months of apixaban is better than 3 months
ID - 3377496
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377496/all/For_patients_with_provoked_venous_thromboembolism_and_at_least_one_ongoing_risk_factor__12_months_of_apixaban_is_better_than_3_months
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
